These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 16544829)
1. Protection of human subjects and scientific progress: can the two be reconciled? Dresser R Hastings Cent Rep; 2006; 36(1):7; author reply 9. PubMed ID: 16544829 [No Abstract] [Full Text] [Related]
2. Protection of human subjects and scientific progress: can the two be reconciled? Herrera CD Hastings Cent Rep; 2006; 36(1):7-8; author reply 9. PubMed ID: 16544830 [No Abstract] [Full Text] [Related]
3. Protection of human subjects and scientific progress: can the two be reconciled? Resnik DB Hastings Cent Rep; 2006; 36(1):4-5; author reply 8-9. PubMed ID: 16544825 [No Abstract] [Full Text] [Related]
4. Protection of human subjects and scientific progress: can the two be reconciled? Glass KC Hastings Cent Rep; 2006; 36(1):4; author reply 8-9. PubMed ID: 16544824 [No Abstract] [Full Text] [Related]
5. Protection of human subjects and scientific progress: can the two be reconciled? Faust HS Hastings Cent Rep; 2006; 36(1):5-6; author reply 8-9. PubMed ID: 16544827 [No Abstract] [Full Text] [Related]
6. Protection of human subjects and scientific progress: can the two be reconciled? King NM Hastings Cent Rep; 2006; 36(1):6-7; author reply 8-9. PubMed ID: 16544828 [No Abstract] [Full Text] [Related]
7. Protection of human subjects and scientific progress: can the two be reconciled? Sodeke SO Hastings Cent Rep; 2006; 36(1):5; author reply 8-9. PubMed ID: 16544826 [No Abstract] [Full Text] [Related]
8. Investigator financial disclosures and its effect on research subjects. Gibbs JN; Guagnano GA Food Drug Law J; 2007; 62(4):727-37. PubMed ID: 18557228 [No Abstract] [Full Text] [Related]
9. Why learning to communicate with our patients is so important: using communication to enhance accrual to cancer clinical trials. Siminoff LA J Clin Oncol; 2008 Jun; 26(16):2614-5. PubMed ID: 18509171 [No Abstract] [Full Text] [Related]
10. Identifying motivations and barriers to patient participation in clinical trials. Jones JM; Nyhof-Young J; Moric J; Friedman A; Wells W; Catton P J Cancer Educ; 2006; 21(4):237-42. PubMed ID: 17542716 [TBL] [Abstract][Full Text] [Related]
11. Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. Helft PR; Daugherty CK J Clin Oncol; 2006 Oct; 24(30):4793-5. PubMed ID: 17050863 [No Abstract] [Full Text] [Related]
12. Willingness of gynecologic cancer patients to participate in clinical trials. Mathews C; Restivo A; Raker C; Weitzen S; Disilvestro P Gynecol Oncol; 2009 Jan; 112(1):161-5. PubMed ID: 18952272 [TBL] [Abstract][Full Text] [Related]
13. The ethics of phase 0 oncology trials. Abdoler E; Taylor H; Wendler D Clin Cancer Res; 2008 Jun; 14(12):3692-7. PubMed ID: 18559585 [TBL] [Abstract][Full Text] [Related]
14. Performance of biopsies in clinical research. Cannistra SA J Clin Oncol; 2007 Apr; 25(11):1454-5. PubMed ID: 17416872 [No Abstract] [Full Text] [Related]
15. Issues related to children participating in clinical research. Knox CA; Burkhart PV J Pediatr Nurs; 2007 Aug; 22(4):310-8. PubMed ID: 17645958 [TBL] [Abstract][Full Text] [Related]
16. Global health research and professional ethics: ancillary care for research participants. Merritt MW Md Med; 2007; 8(3):32-3. PubMed ID: 17970500 [No Abstract] [Full Text] [Related]
17. Patients, profits, and progress. Perry MC Mo Med; 1989 Jul; 86(7):375, 426. PubMed ID: 2796940 [No Abstract] [Full Text] [Related]